In conclusion, our results provide evidence that high Nrf2 expression inhibites MSH2 expression through activating the JNK/c-Jun signaling pathway, playing a key role in the frequency of gene mutation in tumor cells, thus achieving chemoresistance in AML. Here, JUN is linked to acute myeloid leukemia.